Menée à l'aide des données d'une enquête réalisée sur la période 2015-2018 auprès de 12 984 participants, cette étude analyse les comportements tabagiques (cigarette classique ou électronique) chez les personnes ayant survécu à un cancer, qu'il soit associé au tabac ou non

Patterns and associations of smoking and electronic cigarette use among survivors of tobacco related and non-tobacco related cancers: A nationally representative cross-sectional analysis

Bjurlin, Marc A. ; Basak, Ramsankar ; Zambrano, Ibardo ; Schatz, Daniel ; El Shahawy, Omar ; Sherman, Scott ; Matulewicz, Richard S.

Background: Tobacco-use among cancer survivors leads to preventable morbidity, mortality, and increased healthcare costs. We sought to explore the prevalence of smoking and e-cigarette use among survivors of tobacco and non-tobacco related cancers. Methods: A cross-sectional analysis was conducted using the 2015–2018 National Health Interview Survey. Our primary outcome was the prevalence of current cigarette smoking or e-cigarette use among adults with self-reported history of tobacco related [...]

Menée en Australie, au Canada, en Angleterre et aux Etats-Unis par enquêtes réalisées en 2016 et 2018 auprès de 886 utilisateurs de produits de vapotage à la nicotine et de cigarettes, cette étude analyse l'association entre l'utilisation de produits de vapotage aromatisés et le sevrage tabagique

How does the use of flavored nicotine vaping products relate to progression towards quitting smoking? Findings from the 2016 and 2018 ITC 4CV Surveys

Li, Lin ; Borland, Ron ; Cummings, K Michael ; Fong, Geoffrey T ; Gravely, Shannon ; Smith, Danielle M ; Goniewicz, Maciej L ; O’Connor, Richard J ; Thompson, Mary E ; McNeill, Ann

There is limited research on the role of flavors in nicotine vaping products (NVPs) in relation to smoking. We examined patterns of flavor use in NVPs in relation to progression towards quitting.Data come from 886 concurrent users of NVPs (at least weekly) and cigarettes who were first surveyed in 2016 and then successfully recontacted in 2018 as part of the ITC 4CV Surveys conducted in Australia, Canada, England and the United States. Participants were asked about their main vaping flavor [...]

Menée à partir des données d'une étude réalisée sur la période 2013-2018 auprès de 15 776 adolescents n'ayant jamais fumé (âge : 12-17 ans), cette étude évalue l'âge de début du tabagisme en fonction du sexe et de l'origine ethnique

Age at Initiation of Cigarette Use in a Nationally Representative Sample of US Youth, 2013-2017

Pérez, Adriana ; N’hpang, Roi San ; Callahan, Elizabeth ; Bluestein, Meagan ; Kuk, Arnold E. ; Chen, Baojiang ; Perry, Cheryl L. ; Harrell, Melissa B.

Cigarettes are still a commonly used tobacco product among youth despite recent declines in cigarette use.The aim of this study was to prospectively estimate the age of cigarette use initiation among youth (aged 12-17 years) overall, by sex, and by race/ethnicity.This cohort study used data from waves 1 through 4 of the nationally representative Population Assessment of Tobacco and Health (PATH) study, conducted from September 12, 2013, to January 3, 2018. Two subpopulations of youth were [...]

Menée auprès de 4 575 femmes porteuses d'une mutation BRCA1 ou BRCA2 (âge moyen : 55,8-57 ans), cette étude analyse l'effet d'une salpingo-ovariectomie prophylactique sur le risque de cancer du sein

Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic Variants

Choi, Yun-Hee ; Terry, Mary Beth ; Daly, Mary B. ; MacInnis, Robert J. ; Hopper, John L. ; Colonna, Sarah ; Buys, Saundra S. ; Andrulis, Irene L. ; John, Esther M. ; Kurian, Allison W. ; Briollais, Laurent

Women with pathogenic variants in BRCA1 and BRCA2 are at high risk of developing breast and ovarian cancers. They usually undergo intensive cancer surveillance and may also consider surgical interventions, such as risk-reducing mastectomy or risk-reducing salpingo-oophorectomy (RRSO). Risk-reducing salpingo-oophorectomy has been shown to reduce ovarian cancer risk, but its association with breast cancer risk is less clear.To assess the association of RRSO with the risk of breast cancer in women [...]

Menée auprès de 1 703 patients atteints d'un lymphome non hodgkinien et 2 199 témoins, cette étude analyse l'association entre une utilisation d'anti-inflammatoires non-stéroïdiens et/ou de statines et le risque de développer la maladie par sous-type

Aspirin and other nonsteroidal anti-inflammatory drugs, statins, and risk of non-Hodgkin lymphoma

Liebow, Mark ; Larson, Melissa C. ; Thompson, Carrie A. ; Nowakowski, Grzegorz S. ; Call, Timothy G. ; Macon, William R. ; Kay, Neil E. ; Habermann, Thomas M. ; Slager, Susan L. ; Cerhan, James R.

Non-steroidal anti-inflammatory drugs (NSAIDs) and statin drugs may protect against the development of non-Hodgkin lymphoma (NHL), but data are limited, particularly for NHL subtypes. Further, some in vitro, animal, and epidemiologic data suggest there may be a synergistic effect of these two agents, but there has been no test of this hypothesis in NHL. We evaluated the self-reported use of NSAIDs and statins in a clinic-based study of 1703 NHL patients and 2199 frequency-matched controls. [...]

Menée en Suisse en 2017 auprès de 1 112 fumeurs recrutés via un réseau social, cette étude évalue l'intérêt de programmes collectifs de sevrage tabagique du point de vue de l'abstinence continue à 10 jours, 3 mois puis 6 mois

Cessation rates from a national collective social network smoking cessation programme: results from the ‘I quit smoking with Facebook on March 21’ Swiss programme

Desrichard, Olivier ; Moussaoui, Lisa S ; Blondé, Jérôme ; Felder, Max ; Riedo, Gisana ; Folly, Laura ; Falomir-Pichastor, Juan M

Background: Programmes for collective smoking cessation, based on the British model Stoptober, are proposed by public health units in many countries. There is a need for data estimating the rate at which participants in these programmes are successful in quitting smoking. We report a prospective study carried out as part of a large-scale collective cessation programme conducted in Switzerland in 2017. Methods: 1112 participants among the 7008 smokers enrolled in the collective cessation [...]